Jump to main content
Jump to site search

Issue 1, 2012
Previous Article Next Article

The development of quinoloneesters as novel antimalarial agents targeting the Plasmodium falciparum bc1 protein complex

Author affiliations

Abstract

Using the Gould-Jacobs methodology a small array of 6- and 7-substituted quinolones have been prepared. Analogues in the 7-series express activity as low as 0.46 nM versus Plasmodium falciparum malaria parasites and docking studies performed in silico at the yeast Qo site demonstrate a key role for residues His182 and Glu 272 in the recognition of high potency inhibitors.

Graphical abstract: The development of quinolone esters as novel antimalarial agents targeting the Plasmodium falciparum bc1 protein complex

Back to tab navigation

Publication details

The article was received on 15 Jul 2011, accepted on 15 Aug 2011 and first published on 01 Sep 2011


Article type: Concise Article
DOI: 10.1039/C1MD00183C
Med. Chem. Commun., 2012,3, 39-44

  •   Request permissions

    The development of quinolone esters as novel antimalarial agents targeting the Plasmodium falciparum bc1 protein complex

    R. Cowley, S. Leung, N. Fisher, M. Al-Helal, N. G. Berry, A. S. Lawrenson, R. Sharma, A. E. Shone, S. A. Ward, G. A. Biagini and P. M. O′Neill, Med. Chem. Commun., 2012, 3, 39
    DOI: 10.1039/C1MD00183C

Search articles by author

Spotlight

Advertisements